Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
255.80    1.40 (0.55%)
Bid:
254.00
Ask:
254.60
Spread: 0.60 (0.236%)
Market Cap: £2.51b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Transaction in Own Shares

14 Apr 2022 07:00

RNS Number : 3239I
Serco Group PLC
14 April 2022
 

Serco Group plc 

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

 

Transactions in own shares

 

Serco Group plc (the 'Company') announces the purchase of 32,986 ordinary shares of 2 pence each (the 'Ordinary Shares') through J.P. Morgan Securities plc on 13 April 2022.

 

The Company intends to hold all of the purchased Ordinary Shares in treasury.

 

Since the announcement of the share buy-back programme on 24 February 2022 (the 'Programme'), the Company has purchased a total of 7,436,441 Ordinary Shares.

 

Following the transactions referred to in this announcement, the Company holds 7,436,441 Ordinary Shares in treasury and has 1,210,572,347 Ordinary Shares in issue (excluding treasury shares). The total number of Ordinary Shares with voting rights will be 1,210,572,347 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The table below contains detailed information about the purchases referred to above.

 

Schedule of Purchases

 

Shares purchased:

Serco Group plc (ISIN: GB0007973794)

 

Date of purchases:

13 April 2022

 

Investment firm:

J.P. Morgan Securities plc

 

Aggregate information:

 

Venue

Aggregated number of ordinary shares purchased

Volume-weighted average price per share

Lowest price per share

Highest price per share

London Stock Exchange

32,986

148.6748

147.7000

149.7000

Ends

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: paul.checketts@serco.com 

Marcus De Ville, Head of Media Relations, tel: +44 (0) 7738 898 550 or email: marcus.deville@serco.com 

About Serco

Serco is a leading provider of public services. Our customers are governments or others operating in the public sector. We gain scale, expertise and diversification by operating internationally across five sectors and four geographies: Defence, Justice & Immigration, Transport, Health and Citizen Services, delivered in UK & Europe, North America, Asia Pacific and the Middle East. More information can be found at www.serco.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSIJMATMTABBJT
Date   Source Headline
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 202510:04 amRNSDirector Declaration
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20255:00 pmRNSDirector/PDMR Shareholding
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20255:40 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20255:00 pmRNSHolding(s) in Company
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20256:19 pmRNSTransaction in Own Shares and Total Voting Rights
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20259:30 amRNSUpdate Statement on 2025 AGM Voting Results
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20253:00 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20253:00 pmRNSStatement re shareholder consultation
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20252:00 pmRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20254:00 pmRNSHolding(s) in Company
12th Aug 202510:31 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSShare Repurchase Programme
8th Aug 20255:00 pmRNSHolding(s) in Company
7th Aug 20257:00 amRNS2025 half year results
26th Jun 20257:01 amRNSSerco appoints Keith Williams as Board Chair
26th Jun 20257:00 amRNSSerco pre-close trading update
30th May 20259:30 amRNSBlock listing Interim Review
27th May 20257:00 amRNSSerco completes acquisition of MTS
15th May 20257:00 amRNSSerco awarded Maritime Services contracts
13th May 20251:00 pmRNSDirector/PDMR Shareholding
9th May 20253:00 pmRNSDirector/PDMR Shareholding
24th Apr 202512:18 pmRNSResult of AGM and Director Declaration
9th Apr 20255:00 pmRNSDirector/PDMR Shareholding
7th Apr 20255:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.